NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy

Number of the records: 1

1.

SYSNO	0584089
Title	NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
Author(s)	Kafkova, L. R. (CZ) Mierzwicka, Joanna Maria (BTO-N) Chakraborty, P. (CZ) Jakubec, P. (CZ) Fischer, O. (CZ) Škarda, J. (CZ) Malý, Petr (BTO-N)_{RID, ORCID} Raška, M. (CZ)
Corespondence/senior	Kafkova, L. R. - Korespondující autor Raška, M. - Korespondující autor
Source Title	Frontiers in Immunology. Roč. 15, FEB 7 2024 (2024). - : Frontiers Media
Article number	1342086
Document Type	Článek v odborném periodiku
Institutional support	BTO-N - RVO:86652036
Language	eng
Country	CH
Keywords	PD-1 * immune checkpoint * PD-L1 * CELL LUNG-CANCER
Cooperating institutions	Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic Univ Hosp Olomouc, Dept Immunol, Olomouc, Czech Republic Univ Hosp Olomouc, Dept Resp Dis & TB, Olomouc, Czech Republic Palacky Univ Olomouc, Fac Med & Dent, Inst Clin & Mol Pathol, Olomouc, Czech Republic Univ Hosp Ostrava, Dept Pathol, Ostrava, Czech Republic Univ Ostrava, Fac Med, Ostrava, Czech Republic
URL	https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342086/full
Permanent Link	https://hdl.handle.net/11104/0353420

Number of the records: 1